Zhaozhou Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhaozhou Zhang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Ling Zhao
School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
20 shared publications - Fengjing Jia
School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
19 shared publications - Fuwen Yuan
The Center for Cancer Research, School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
19 shared publications - Jiao Wei
School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
19 shared publications - Jinming Li
Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
19 shared publications - Ru Jia
Department of Medical Oncology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
19 shared publications
Latest Publications
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment
Bsh-expressing gut microbiota mediates liver metastasis in CRC mice
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment
Bsh-expressing gut microbiota mediates liver metastasis in CRC mice
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Data from Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment
The gut microbiome is frequently dysregulated in colorectal cancer. Gut microbiota can modify bile acids (BA), which is a group of metabolites that have been linked to tumorigenesis and progression. In this study, we observed a significant deficiency in gut bacteria with bile salt hydrolase (BSH) activity in patients with liver metastatic colorectal cancer (CRLM). These patients exhibited elevated levels of conjugated primary BAs (CPBA) and decreased levels of unconjugated BAs (UBA) in their circulation. The changes in bacterial BSH activity and CPBA levels were more pronounced in male patients with CRLM. Microbial manipulation in mouse colorectal cancer models to create a BSH-deficient state increased CPBAs, reduced UBAs, and promoted liver metastasis. Specifically, taurocholic acid (TCA), a CPBA, promoted CRLM through a neutrophil-dependent mechanism. TCA upregulated TIMP1 in colorectal cancer cells, which in turn stimulated CXCL5/CXCR2-mediated neutrophil recruitment and CRLM. Alternatively, unconjugated primary and secondary BAs counteracted neutrophil migration induced by TCA in vitro and abolished TCA-promoted neutrophil recruitment and liver metastasis in vivo. Together, these findings elucidate a mechanistic role of the dysregulated gut microbiota–BA axis in CRLM, suggesting that manipulating the balance between conjugated and UBAs could be a potential therapeutic strategy to suppress colorectal cancer metastasis.Significance:In colorectal cancer, enrichment of bile salt hydrolase-deficient gut microbiota elevates conjugated primary bile acids that promote liver metastasis by inducing TIMP1-mediated neutrophil recruitment, which can be reversed by supplementing with unconjugated bile acids.
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment
The gut microbiome is frequently dysregulated in colorectal cancer. Gut microbiota can modify bile acids (BA), which is a group of metabolites that have been linked to tumorigenesis and progression. In this study, we observed a significant deficiency in gut bacteria with bile salt hydrolase (BSH) activity in patients with liver metastatic colorectal cancer (CRLM). These patients exhibited elevated levels of conjugated primary BAs (CPBA) and decreased levels of unconjugated BAs (UBA) in their circulation. The changes in bacterial BSH activity and CPBA levels were more pronounced in male patients with CRLM. Microbial manipulation in mouse colorectal cancer models to create a BSH-deficient state increased CPBAs, reduced UBAs, and promoted liver metastasis. Specifically, taurocholic acid (TCA), a CPBA, promoted CRLM through a neutrophil-dependent mechanism. TCA upregulated TIMP1 in colorectal cancer cells, which in turn stimulated CXCL5/CXCR2-mediated neutrophil recruitment and CRLM. Alternatively, unconjugated primary and secondary BAs counteracted neutrophil migration induced by TCA in vitro and abolished TCA-promoted neutrophil recruitment and liver metastasis in vivo. Together, these findings elucidate a mechanistic role of the dysregulated gut microbiota–BA axis in CRLM, suggesting that manipulating the balance between conjugated and UBAs could be a potential therapeutic strategy to suppress colorectal cancer metastasis.Significance:In colorectal cancer, enrichment of bile salt hydrolase-deficient gut microbiota elevates conjugated primary bile acids that promote liver metastasis by inducing TIMP1-mediated neutrophil recruitment, which can be reversed by supplementing with unconjugated bile acids.
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Table S5 from Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment
16s rRNA sequence of colorectal cancer with/without liver metastasis
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment
16s rRNA sequence of colorectal cancer with/without liver metastasis
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Table S2 from Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment
Characteristics of colorectal cancer patients in the cohort I group
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment
Characteristics of colorectal cancer patients in the cohort I group
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S7 from Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment
Flow cytometric analysis and immunofluorescence stain of immune cells in the primary foci in the mice treated with TCA
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment
Flow cytometric analysis and immunofluorescence stain of immune cells in the primary foci in the mice treated with TCA
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Table S6 from Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment
Calculation of cut-off value of serum conjugated primary bile acids
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment
Calculation of cut-off value of serum conjugated primary bile acids
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Method from Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment
Sequence of TIMP1 promoter applied in the luciferase assay
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Method from Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment
Sequence of TIMP1 promoter applied in the luciferase assay
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S9 from Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment
Unconjugated BAs abolish CPBA-promoted liver metastasis in CRC mice
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S9 from Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment
Unconjugated BAs abolish CPBA-promoted liver metastasis in CRC mice
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment
CPBAs promote liver metastasis in CRC mice induced by orthotopic implantation or intrasplenic injection
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment
CPBAs promote liver metastasis in CRC mice induced by orthotopic implantation or intrasplenic injection
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Table S4 from Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment
Clinical characteristics of colorectal cancer patients in the cohort II group
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment
Clinical characteristics of colorectal cancer patients in the cohort II group